Skip to main content

Release notes v2.4.0-2.0.0

· 3 min read
Elliott Gordon
Elliott Gordon
Product manager

✨ New in This Release​

Adjusted body weight support in obesity-related dosing workflows

Touchdose now supports adjusted body weight (AdjBW) where the underlying formulary instructs its use for obese patients. This means obesity-related dose calculations and smart alerts can now refer to either ideal body weight (IBW) or AdjBW, depending on the formulary content and the patient context.

Where relevant, the patient header also now shows adjusted body weight as a derived patient parameter, alongside the method used to calculate it.

Clearer handling of medication-context launch failures

In medication-context launch workflows, Touchdose now more clearly depends on successful medication lookup before the prescribing flow can continue. If the incoming medication cannot be resolved from the launch context, the user cannot proceed into indication selection for that launch.

Blocking order writeback where it cannot be performed safely

Order writeback can now be deliberately blocked for orders that cannot be safely or correctly transferred into the EP System's order form — for example a continuous infusion, whose dose is expressed as a rate that the order form cannot represent. When writeback is blocked for an order, the Add order button remains disabled even when all decisions within Touchdose have been completed, in the same way it does when a required decision is still outstanding. The clinician completes the order using the standard EP System order form, exactly as they would when viewing dose recommendations outside the ordering workflow.

This behaviour is controlled per client through the localisation mapping configuration, so which orders are blocked is determined by each organisation's setup. It is distinct from the existing case where an individual field simply has no equivalent in the EP System: there, the order is still written back with that one field left blank, whereas a blocked order is not written back at all.

For full details, see Limitations relating to order writeback into the EP System and Adding the order to the EP System.

🔧 Maintenance​

Order writeback field mapping updates

Order writeback mappings have been updated to better support separate strength-based and volume-based dose fields where required by the integration.

📘 Documentation​

The Instructions for Use document has been updated to reflect the changes in this release. Highlights:

  • Dosing weight guidance updated to reflect support for both IBW and AdjBW in obese patients where required by the formulary.
  • Derived patient parameters updated with a dedicated AdjBW section and patient-header display details.
  • Smart alert guidance updated so obesity alerts can describe either IBW or AdjBW.
  • Glossary updated with the AdjBW definition.
  • Medication-context launch guidance clarified in line with medication lookup requirements.
  • Adding the order to the EP System on the Medication order page now explains that the Add order button can remain disabled for orders that cannot be safely written back, with the clinician completing the order manually on the EP System order form.
  • The Limitations relating to order writeback into the EP System section now distinguishes a blocked order (not written back at all) from a single unmapped field (written back with that field left blank).